Showing results (131-140 of 231) with videos related to
Sort By:
Pageof 24
Rheumatology and Therapy|April 5, 2025
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic AgentsAnca D Askanase, Richard Furie, Maria Dall'Era, et al.Arthritis Research & Therapy|February 8, 2019
Rheumatoid arthritis reprograms circadian output pathwaysToryn M Poolman, Julie Gibbs, Amy L Walker, et al.The Lancet. Rheumatology|January 17, 2024
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trialRichard A Furie, Eric F Morand, Ian N Bruce, et al.Lupus Science & Medicine|March 29, 2022
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteriaRonald van Vollenhoven, Anca D Askanase, Andrew S Bomback, et al.Magnetic Resonance Imaging|October 17, 2022
Imaging biomarkers of lung ventilation in interstitial lung disease from 129Xe and oxygen enhanced 1H MRIMarta Tibiletti, James A Eaden, Josephine H Naish, et al.Journal of Clinical Medicine|October 18, 2018
Drug-Induced Interstitial Lung Disease: A Systematic ReviewSarah Skeoch, Nicholas Weatherley, Andrew J Swift, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2022
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus ErythematosusKenneth C Kalunian, Richard Furie, Eric F Morand, et al.Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.Rheumatology (Oxford, England)|February 26, 2010
Numerical scoring for the BILAG-2004 indexChee-Seng Yee, Lynne Cresswell, Vernon Farewell, et al.Lupus Science & Medicine|May 22, 2024
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestationsAnca D Askanase, Richard A Furie, Maria Dall'Era, et al.Pageof 24